Potential for medication overdose with ENFit low dose tip syringes

October 13, 2021

The U.S. Food and Drug Administration (FDA) issued a safety communication informing patients and health care providers about the potential for overdose, under certain clinical use conditions, when using ENFit low dose tip (LDT) syringes.

The FDA is providing recommendations for patients and health care providers to promote the safe use of ENFit LDT syringes, including the steps users can take to optimize dose accuracy. When using the recommended steps included in the safety communication, the dose accuracy of the ENFit LDT syringes is equivalent to the dose accuracy of traditional syringes.